▶ 調査レポート

注射型スマトリプタンの世界市場 2020年

• 英文タイトル:Global Injectable Sumatriptan Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが調査・発行した産業分析レポートです。注射型スマトリプタンの世界市場 2020年 / Global Injectable Sumatriptan Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025 / GIR201112547資料のイメージです。• レポートコード:GIR201112547
• 出版社/出版日:GlobalInfoResearch / 2020年10月20日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、105ページ
• 納品方法:Eメール
• 産業分類:医薬品・医療
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Multi User¥772,560 (USD5,220)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本書では、注射型スマトリプタンの世界市場を調査対象にし、注射型スマトリプタンの市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析(北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ)、種類別分析(4mg、6mg、その他)、用途別分析(病院、診療所、その他)、市場予測(2021年~2025年)、販売チャンネル・代理店分析情報などを整理しました。
・市場概要
・メーカー情報:GlaxoSmithKline、Sun Pharma、Pfizer、Teva
・メーカー別販売量、売上、市場シェア
・注射型スマトリプタンの地域別市場分析
・注射型スマトリプタンの北米市場規模2015-2020:アメリカ、カナダ、メキシコ
・注射型スマトリプタンのヨーロッパ市場規模2015-2020:ドイツ、イギリス、フランス、ロシアなど
・注射型スマトリプタンのアジア市場規模2015-2020:日本、中国、韓国、インド、東南アジアなど
・注射型スマトリプタンの南米市場規模2015-2020:ブラジル、アルゼンチンなど
・注射型スマトリプタンの中東・アフリカ市場規模2015-2020:サウジアラビア、トルコ、エジプト、南アフリカなど
・注射型スマトリプタンの種類別市場規模2015-2020:4mg、6mg、その他
・注射型スマトリプタンの用途別市場規模2015-2020:病院、診療所、その他
・注射型スマトリプタンの世界市場予測2021-2025:地域別、種類別、用途別
・販売チャンネル・代理店分析
・調査の結果・結論

Market Overview
The Injectable Sumatriptan market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The global Injectable Sumatriptan market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

Market segmentation
Injectable Sumatriptan market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Injectable Sumatriptan market has been segmented into
4mg
6mg
Others

By Application, Injectable Sumatriptan has been segmented into:
Hospitals
Clinics
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Injectable Sumatriptan market presented in the report. This section sheds light on the sales growth of different regional and country-level Injectable Sumatriptan markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Injectable Sumatriptan market.

The report offers in-depth assessment of the growth and other aspects of the Injectable Sumatriptan market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Injectable Sumatriptan Market Share Analysis
Injectable Sumatriptan competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Injectable Sumatriptan sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Injectable Sumatriptan sales, revenue and market share for each player covered in this report.

The major players covered in Injectable Sumatriptan are:
GlaxoSmithKline
Sun Pharma
Pfizer
Teva

Among other players domestic and global, Injectable Sumatriptan market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Injectable Sumatriptan product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Injectable Sumatriptan, with price, sales, revenue and global market share of Injectable Sumatriptan in 2018 and 2019.
Chapter 3, the Injectable Sumatriptan competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Injectable Sumatriptan breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Injectable Sumatriptan market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Injectable Sumatriptan sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

1 Market Overview
1.1 Injectable Sumatriptan Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Injectable Sumatriptan Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 4mg
1.2.3 6mg
1.2.4 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Injectable Sumatriptan Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Overview of Global Injectable Sumatriptan Market
1.4.1 Global Injectable Sumatriptan Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 GlaxoSmithKline
2.1.1 GlaxoSmithKline Details
2.1.2 GlaxoSmithKline Major Business
2.1.3 GlaxoSmithKline SWOT Analysis
2.1.4 GlaxoSmithKline Product and Services
2.1.5 GlaxoSmithKline Injectable Sumatriptan Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Sun Pharma
2.2.1 Sun Pharma Details
2.2.2 Sun Pharma Major Business
2.2.3 Sun Pharma SWOT Analysis
2.2.4 Sun Pharma Product and Services
2.2.5 Sun Pharma Injectable Sumatriptan Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business
2.3.3 Pfizer SWOT Analysis
2.3.4 Pfizer Product and Services
2.3.5 Pfizer Injectable Sumatriptan Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Teva
2.4.1 Teva Details
2.4.2 Teva Major Business
2.4.3 Teva SWOT Analysis
2.4.4 Teva Product and Services
2.4.5 Teva Injectable Sumatriptan Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Injectable Sumatriptan Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Injectable Sumatriptan Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Injectable Sumatriptan Manufacturer Market Share in 2019
3.3.2 Top 6 Injectable Sumatriptan Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Injectable Sumatriptan Sales, Revenue and Market Share by Regions
4.1.1 Global Injectable Sumatriptan Sales and Market Share by Regions (2015-2020)
4.1.2 Global Injectable Sumatriptan Revenue and Market Share by Regions (2015-2020)
4.2 North America Injectable Sumatriptan Sales and Growth Rate (2015-2020)
4.3 Europe Injectable Sumatriptan Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Injectable Sumatriptan Sales and Growth Rate (2015-2020)
4.5 South America Injectable Sumatriptan Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Injectable Sumatriptan Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Injectable Sumatriptan Sales, Revenue and Market Share by Country
5.1.1 North America Injectable Sumatriptan Sales and Market Share by Country (2015-2020)
5.1.2 North America Injectable Sumatriptan Revenue and Market Share by Country (2015-2020)
5.2 United States Injectable Sumatriptan Sales and Growth Rate (2015-2020)
5.3 Canada Injectable Sumatriptan Sales and Growth Rate (2015-2020)
5.4 Mexico Injectable Sumatriptan Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Injectable Sumatriptan Sales, Revenue and Market Share by Country
6.1.1 Europe Injectable Sumatriptan Sales and Market Share by Country (2015-2020)
6.1.2 Europe Injectable Sumatriptan Revenue and Market Share by Country (2015-2020)
6.2 Germany Injectable Sumatriptan Sales and Growth Rate (2015-2020)
6.3 UK Injectable Sumatriptan Sales and Growth Rate (2015-2020)
6.4 France Injectable Sumatriptan Sales and Growth Rate (2015-2020)
6.5 Russia Injectable Sumatriptan Sales and Growth Rate (2015-2020)
6.6 Italy Injectable Sumatriptan Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Injectable Sumatriptan Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Injectable Sumatriptan Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Injectable Sumatriptan Revenue and Market Share by Regions (2015-2020)
7.2 China Injectable Sumatriptan Sales and Growth Rate (2015-2020)
7.3 Japan Injectable Sumatriptan Sales and Growth Rate (2015-2020)
7.4 Korea Injectable Sumatriptan Sales and Growth Rate (2015-2020)
7.5 India Injectable Sumatriptan Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Injectable Sumatriptan Sales and Growth Rate (2015-2020)
7.7 Australia Injectable Sumatriptan Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Injectable Sumatriptan Sales, Revenue and Market Share by Country
8.1.1 South America Injectable Sumatriptan Sales and Market Share by Country (2015-2020)
8.1.2 South America Injectable Sumatriptan Revenue and Market Share by Country (2015-2020)
8.2 Brazil Injectable Sumatriptan Sales and Growth Rate (2015-2020)
8.3 Argentina Injectable Sumatriptan Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Injectable Sumatriptan Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Injectable Sumatriptan Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Injectable Sumatriptan Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Injectable Sumatriptan Sales and Growth Rate (2015-2020)
9.3 Turkey Injectable Sumatriptan Sales and Growth Rate (2015-2020)
9.4 Egypt Injectable Sumatriptan Sales and Growth Rate (2015-2020)
9.5 South Africa Injectable Sumatriptan Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Injectable Sumatriptan Sales and Market Share by Type (2015-2020)
10.2 Global Injectable Sumatriptan Revenue and Market Share by Type (2015-2020)
10.3 Global Injectable Sumatriptan Price by Type (2015-2020)
11 Global Injectable Sumatriptan Market Segment by Application
11.1 Global Injectable Sumatriptan Sales Market Share by Application (2015-2020)
11.2 Global Injectable Sumatriptan Revenue Market Share by Application (2015-2020)
11.3 Global Injectable Sumatriptan Price by Application (2015-2020)
12 Market Forecast
12.1 Global Injectable Sumatriptan Sales, Revenue and Growth Rate (2021-2025)
12.2 Injectable Sumatriptan Market Forecast by Regions (2021-2025)
12.2.1 North America Injectable Sumatriptan Market Forecast (2021-2025)
12.2.2 Europe Injectable Sumatriptan Market Forecast (2021-2025)
12.2.3 Asia-Pacific Injectable Sumatriptan Market Forecast (2021-2025)
12.2.4 South America Injectable Sumatriptan Market Forecast (2021-2025)
12.2.5 Middle East & Africa Injectable Sumatriptan Market Forecast (2021-2025)
12.3 Injectable Sumatriptan Market Forecast by Type (2021-2025)
12.3.1 Global Injectable Sumatriptan Sales Forecast by Type (2021-2025)
12.3.2 Global Injectable Sumatriptan Market Share Forecast by Type (2021-2025)
12.4 Injectable Sumatriptan Market Forecast by Application (2021-2025)
12.4.1 Global Injectable Sumatriptan Sales Forecast by Application (2021-2025)
12.4.2 Global Injectable Sumatriptan Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables
Table 1. Global Injectable Sumatriptan Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Injectable Sumatriptan by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Injectable Sumatriptan Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Injectable Sumatriptan Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 9. GlaxoSmithKline Injectable Sumatriptan Major Business
Table 10. GlaxoSmithKline Injectable Sumatriptan Total Revenue (USD Million) (2018-2019)
Table 11. GlaxoSmithKline SWOT Analysis
Table 12. GlaxoSmithKline Injectable Sumatriptan Product and Services
Table 13. GlaxoSmithKline Injectable Sumatriptan Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. Sun Pharma Basic Information, Manufacturing Base and Competitors
Table 15. Sun Pharma Injectable Sumatriptan Major Business
Table 16. Sun Pharma Injectable Sumatriptan Total Revenue (USD Million) (2018-2019)
Table 17. Sun Pharma SWOT Analysis
Table 18. Sun Pharma Injectable Sumatriptan Product and Services
Table 19. Sun Pharma Injectable Sumatriptan Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Pfizer Basic Information, Manufacturing Base and Competitors
Table 21. Pfizer Injectable Sumatriptan Major Business
Table 22. Pfizer Injectable Sumatriptan Total Revenue (USD Million) (2018-2019)
Table 23. Pfizer SWOT Analysis
Table 24. Pfizer Injectable Sumatriptan Product and Services
Table 25. Pfizer Injectable Sumatriptan Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. Teva Basic Information, Manufacturing Base and Competitors
Table 27. Teva Injectable Sumatriptan Major Business
Table 28. Teva Injectable Sumatriptan Total Revenue (USD Million) (2018-2019)
Table 29. Teva SWOT Analysis
Table 30. Teva Injectable Sumatriptan Product and Services
Table 31. Teva Injectable Sumatriptan Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. Global Injectable Sumatriptan Sales by Manufacturer (2018-2019) (K Units)
Table 33. Global Injectable Sumatriptan Revenue by Manufacturer (2018-2019) (USD Million)
Table 34. Global Injectable Sumatriptan Sales by Regions (2015-2020) (K Units)
Table 35. Global Injectable Sumatriptan Sales Market Share by Regions (2015-2020)
Table 36. Global Injectable Sumatriptan Revenue by Regions (2015-2020) (USD Million)
Table 37. North America Injectable Sumatriptan Sales by Countries (2015-2020) (K Units)
Table 38. North America Injectable Sumatriptan Sales Market Share by Countries (2015-2020)
Table 39. North America Injectable Sumatriptan Revenue by Countries (2015-2020) (USD Million)
Table 40. North America Injectable Sumatriptan Revenue Market Share by Countries (2015-2020)
Table 41. Europe Injectable Sumatriptan Sales by Countries (2015-2020) (K Units)
Table 42. Europe Injectable Sumatriptan Sales Market Share by Countries (2015-2020)
Table 43. Europe Injectable Sumatriptan Revenue by Countries (2015-2020) (USD Million)
Table 44. Asia-Pacific Injectable Sumatriptan Sales by Regions (2015-2020) (K Units)
Table 45. Asia-Pacific Injectable Sumatriptan Sales Market Share by Regions (2015-2020)
Table 46. Asia-Pacific Injectable Sumatriptan Revenue by Regions (2015-2020) (USD Million)
Table 47. South America Injectable Sumatriptan Sales by Countries (2015-2020) (K Units)
Table 48. South America Injectable Sumatriptan Sales Market Share by Countries (2015-2020)
Table 49. South America Injectable Sumatriptan Revenue by Countries (2015-2020) (USD Million)
Table 50. South America Injectable Sumatriptan Revenue Market Share by Countries (2015-2020)
Table 51. Middle East & Africa Injectable Sumatriptan Sales by Countries (2015-2020) (K Units)
Table 52. Middle East & Africa Injectable Sumatriptan Sales Market Share by Countries (2015-2020)
Table 53. Middle East & Africa Injectable Sumatriptan Revenue by Countries (2015-2020) (USD Million)
Table 54. Middle East & Africa Injectable Sumatriptan Revenue Market Share by Countries (2015-2020)
Table 55. Global Injectable Sumatriptan Sales by Type (2015-2020) (K Units)
Table 56. Global Injectable Sumatriptan Sales Share by Type (2015-2020)
Table 57. Global Injectable Sumatriptan Revenue by Type (2015-2020) (USD Million)
Table 58. Global Injectable Sumatriptan Revenue Share by Type (2015-2020)
Table 59. Global Injectable Sumatriptan Sales by Application (2015-2020) (K Units)
Table 60. Global Injectable Sumatriptan Sales Share by Application (2015-2020)
Table 61. Global Injectable Sumatriptan Sales Forecast by Regions (2021-2025) (K Units)
Table 62. Global Injectable Sumatriptan Market Share Forecast by Regions (2021-2025)
Table 63. Global Injectable Sumatriptan Sales Forecast by Type (2021-2025) (K Units)
Table 64. Global Injectable Sumatriptan Market Share Forecast by Type (2021-2025)
Table 65. Global Injectable Sumatriptan Sales Forecast by Application (2021-2025)
Table 66. Global Injectable Sumatriptan Market Share Forecast by Application (2021-2025)
Table 67. Direct Channel Pros & Cons
Table 68. Indirect Channel Pros & Cons
Table 69. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Injectable Sumatriptan Picture
Figure 2. Global Sales Market Share of Injectable Sumatriptan by Type in 2019
Figure 3. 4mg Picture
Figure 4. 6mg Picture
Figure 5. Others Picture
Figure 6. Injectable Sumatriptan Sales Market Share by Application in 2019
Figure 7. Hospitals Picture
Figure 8. Clinics Picture
Figure 9. Others Picture
Figure 10. Global Injectable Sumatriptan Market Status and Outlook (2015-2025) (USD Million)
Figure 11. United States Injectable Sumatriptan Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Canada Injectable Sumatriptan Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Mexico Injectable Sumatriptan Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Germany Injectable Sumatriptan Revenue (Value) and Growth Rate (2015-2025)
Figure 15. France Injectable Sumatriptan Revenue (Value) and Growth Rate (2015-2025)
Figure 16. UK Injectable Sumatriptan Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Russia Injectable Sumatriptan Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Italy Injectable Sumatriptan Revenue (Value) and Growth Rate (2015-2025)
Figure 19. China Injectable Sumatriptan Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Japan Injectable Sumatriptan Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Korea Injectable Sumatriptan Revenue (Value) and Growth Rate (2015-2025)
Figure 22. India Injectable Sumatriptan Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Southeast Asia Injectable Sumatriptan Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Australia Injectable Sumatriptan Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 25. Brazil Injectable Sumatriptan Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Egypt Injectable Sumatriptan Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Saudi Arabia Injectable Sumatriptan Revenue (Value) and Growth Rate (2015-2025)
Figure 28. South Africa Injectable Sumatriptan Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Turkey Injectable Sumatriptan Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Global Injectable Sumatriptan Sales Market Share by Manufacturer in 2019
Figure 31. Global Injectable Sumatriptan Revenue Market Share by Manufacturer in 2019
Figure 32. Top 3 Injectable Sumatriptan Manufacturer (Revenue) Market Share in 2019
Figure 33. Top 6 Injectable Sumatriptan Manufacturer (Revenue) Market Share in 2019
Figure 34. Key Manufacturer Market Share Trend
Figure 35. Global Injectable Sumatriptan Sales and Growth Rate (2015-2020) (K Units)
Figure 36. Global Injectable Sumatriptan Revenue and Growth Rate (2015-2020) (USD Million)
Figure 37. Global Injectable Sumatriptan Revenue Market Share by Regions (2015-2020)
Figure 38. Global Injectable Sumatriptan Revenue Market Share by Regions in 2018
Figure 39. North America Injectable Sumatriptan Sales and Growth Rate (2015-2020)
Figure 40. Europe Injectable Sumatriptan Sales and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Injectable Sumatriptan Sales and Growth Rate (2015-2020)
Figure 42. South America Injectable Sumatriptan Sales and Growth Rate (2015-2020)
Figure 43. Middle East & Africa Injectable Sumatriptan Sales and Growth Rate (2015-2020)
Figure 44. North America Injectable Sumatriptan Revenue and Growth Rate (2015-2020) (USD Million)
Figure 45. North America Injectable Sumatriptan Sales Market Share by Countries (2015-2020)
Figure 46. North America Injectable Sumatriptan Sales Market Share by Countries in 2018
Figure 47. North America Injectable Sumatriptan Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 48. North America Injectable Sumatriptan Revenue Market Share by Countries in 2018
Figure 49. United States Injectable Sumatriptan Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Canada Injectable Sumatriptan Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Mexico Injectable Sumatriptan Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Europe Injectable Sumatriptan Revenue and Growth Rate (2015-2020) (USD Million)
Figure 53. Europe Injectable Sumatriptan Revenue Market Share by Countries (2015-2020)
Figure 54. Europe Injectable Sumatriptan Revenue Market Share by Countries in 2019
Figure 55. Germany Injectable Sumatriptan Sales and Growth Rate (2015-2020) (K Units)
Figure 56. UK Injectable Sumatriptan Sales and Growth Rate (2015-2020) (K Units)
Figure 57. France Injectable Sumatriptan Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Russia Injectable Sumatriptan Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Italy Injectable Sumatriptan Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Asia-Pacific Injectable Sumatriptan Revenue and Growth Rate (2015-2020) (USD Million)
Figure 61. Asia-Pacific Injectable Sumatriptan Sales Market Share by Regions 2019
Figure 62. Asia-Pacific Injectable Sumatriptan Revenue Market Share by Regions 2019
Figure 63. China Injectable Sumatriptan Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Japan Injectable Sumatriptan Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Korea Injectable Sumatriptan Sales and Growth Rate (2015-2020) (K Units)
Figure 66. India Injectable Sumatriptan Sales and Growth Rate (2015-2020) (K Units)
Figure 67. Southeast Asia Injectable Sumatriptan Sales and Growth Rate (2015-2020) (K Units)
Figure 68. South America Injectable Sumatriptan Revenue and Growth Rate (2015-2020) (USD Million)
Figure 69. South America Injectable Sumatriptan Sales Market Share by Countries in 2019
Figure 70. South America Injectable Sumatriptan Revenue Market Share by Countries in 2019
Figure 71. Brazil Injectable Sumatriptan Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Argentina Injectable Sumatriptan Sales and Growth Rate (2015-2020) (K Units)
Figure 73. Middle East and Africa Injectable Sumatriptan Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. Middle East and Africa Injectable Sumatriptan Sales Market Share by Countries in 2019
Figure 75. Middle East and Africa Injectable Sumatriptan Revenue Market Share by Countries (2015-2020)
Figure 76. Middle East and Africa Injectable Sumatriptan Revenue Market Share by Countries in 2019
Figure 77. Saudi Arabia Injectable Sumatriptan Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Egypt Injectable Sumatriptan Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Turkey Injectable Sumatriptan Sales and Growth Rate (2015-2020) (K Units)
Figure 80. South Africa Injectable Sumatriptan Sales and Growth Rate (2015-2020) (K Units)
Figure 81. Global Injectable Sumatriptan Sales and Growth Rate (2021-2025) (K Units)
Figure 82. Global Injectable Sumatriptan Revenue and Growth Rate (2021-2025) (USD Million)
Figure 83. North America Sales Injectable Sumatriptan Market Forecast (2021-2025) (K Units)
Figure 84. Europe Sales Injectable Sumatriptan Market Forecast (2021-2025) (K Units)
Figure 85. Asia-Pacific Sales Injectable Sumatriptan Market Forecast (2021-2025) (K Units)
Figure 86. South America Sales Injectable Sumatriptan Market Forecast (2021-2025) (K Units)
Figure 87. Middle East & Africa Sales Injectable Sumatriptan Market Forecast (2021-2025) (K Units)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel